Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double Blind Study to Compare the Efficacy Between Cilostazol and Aspirin on White Matter Changes by Cerebral Small Vessel Disease

NCT01932203 is registered in ClinicalTrials.gov with Inha University Hospital as lead sponsor.

NCT NCT01932203
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01932203 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double Blind Study to Compare the Efficacy Between Cilostazol and Aspirin on White Matter Changes by Cerebral Small Vessel Disease
Lead sponsor
Inha University Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
July 17, 2013
Completion date
August 31, 2019
Enrollment
255 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral small vessel disease